Dorbala Sharmila, Shaw Leslee J
Noninvasive Cardiovascular Imaging Program, Departments of Radiology and Medicine (Cardiology), Harvard Medical School, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA.
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA.
J Nucl Cardiol. 2016 Oct;23(5):973-975. doi: 10.1007/s12350-016-0604-2. Epub 2016 Jul 25.
Mortality from coronary artery disease in women declined from nearly 500,000 deaths in 2000 to 398,096 deaths in 2013. Despite these significant gains, cardiovascular disease mortality in women remains unacceptably high. Much additional progress in awareness, evaluation, and management of cardiovascular diseases is needed. Progress in cardiovascular imaging, over the past four decades, has substantially improved the evaluation and management of ischemic heart disease. Ischemic heart disease is now diagnosed early and with greater accuracy, leading to improved risk assessment and timely therapies. The next gains in ischemic heart disease mortality in women will probably be due to application of these imaging advances in a personalized fashion. Thoughtful leaders provide their viewpoints on the use of imaging in the evaluation and management of ischemic heart disease in women.
女性冠状动脉疾病死亡率从2000年的近50万例死亡降至2013年的398,096例死亡。尽管取得了这些显著进展,但女性心血管疾病死亡率仍然高得令人无法接受。在心血管疾病的认知、评估和管理方面还需要取得更多进展。在过去的四十年里,心血管成像技术的进步极大地改善了缺血性心脏病的评估和管理。现在,缺血性心脏病能够被早期诊断且准确性更高,从而改善了风险评估并实现了及时治疗。女性缺血性心脏病死亡率的进一步下降可能将得益于以个性化方式应用这些成像技术进展。有见地的领导者们就成像技术在女性缺血性心脏病评估和管理中的应用发表了他们的观点。